TY - JOUR T1 - Cannabinoids and glaucoma JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 708 LP - 713 DO - 10.1136/bjo.2003.032250 VL - 88 IS - 5 AU - I Tomida AU - R G Pertwee AU - A Azuara-Blanco Y1 - 2004/05/01 UR - http://bjo.bmj.com/content/88/5/708.abstract N2 - Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma. ER -